Literature DB >> 22761339

GLI1 modulates EMT in pancreatic cancer--letter.

Shingo Inaguma, Kenji Kasai, Mitsuyoshi Hashimoto, Hiroshi Ikeda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22761339     DOI： 10.1158/0008-5472.CAN-12-0379

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Upregulation of PTEN suppresses invasion in Tca8113 tongue cancer cells through repression of epithelial-mesenchymal transition (EMT).

Authors:  Siming Xie; Zhiyuan Lu; Yanzhu Lin; Lijia Shen; Cao Yin
Journal:  Tumour Biol       Date:  2015-12-09

2.  MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells.

Authors:  Bing Guan; Lijun Mu; Linlin Zhang; Ke Wang; Juanhua Tian; Shan Xu; Xinyang Wang; Dalin He; Yuefeng Du
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

3.  Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas.

Authors:  Dongsheng Yue; Hui Li; Juanjuan Che; Yi Zhang; Hsin-Hui K Tseng; Joy Q Jin; Thomas M Luh; Etienne Giroux-Leprieur; Minli Mo; Qingfeng Zheng; Huaiyin Shi; Hua Zhang; Xishan Hao; Changli Wang; David M Jablons; Biao He
Journal:  J Exp Clin Cancer Res       Date:  2014-04-24

4.  Addiction of pancreatic cancer cells to zinc-finger transcription factor ZIC2.

Authors:  Shingo Inaguma; Hideaki Ito; Miho Riku; Hiroshi Ikeda; Kenji Kasai
Journal:  Oncotarget       Date:  2015-09-29

Review 5.  Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease.

Authors:  James H Monkman; Erik W Thompson; Shivashankar H Nagaraj
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

6.  Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma.

Authors:  Lei Wang; Joy Q Jin; Yong Zhou; Ziqiang Tian; David M Jablons; Biao He
Journal:  Oncotarget       Date:  2017-12-01

Review 7.  Promising molecular mechanisms responsible for gemcitabine resistance in cancer.

Authors:  Yanfei Jia; Jingwu Xie
Journal:  Genes Dis       Date:  2015-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.